32 results
10-K
2022 FY
EX-10.20
OBSVF
ObsEva SA
31 Mar 23
Annual report
4:01pm
, Buyer shall pay, or cause to be paid, the Purchase Price, minus the Expense Reimbursement Amount in accordance with Section 12, to Seller. Payment … Reimbursement Amount, in accordance with Section 3(b) and Section 12.
5.Further Assurances; Recordation; Covenants.
(a)From and after the date
10-K
2022 FY
OBSVF
ObsEva SA
31 Mar 23
Annual report
4:01pm
or with collaborators;
Failure to obtain or maintain coverage and adequate reimbursement for our product candidate, if approved, could limit our ability to market … and reform government program reimbursement methodologies for products. Moreover, Congress is considering additional health reform measures. For example
F-3
EX-4.2
OBSVF
ObsEva SA
9 Dec 22
Shelf registration (foreign)
7:06am
or Issuance or Securities
Section 7.04
May Hold Securities
Section 7.05
Moneys Held in Trust
Section 7.06
Compensation and Reimbursement
Section 7.07 … by it hereunder except such as it may agree with the Company to pay thereon.
Section 7.06 Compensation and Reimbursement.
(a) The Company shall pay to the Trustee
6-K
OBSVF
ObsEva SA
1 Dec 22
Index to Unaudited Condensed Consolidated Financial Statements
4:15pm
rule finalizing the changes to the Quality Payment Program. At this time, the full impact to overall physician reimbursement under the Medicare … program as a result of the introduction of the Quality Payment Program remains unclear. Any reduction in reimbursement from Medicare or other government
6-K
OBSVF
ObsEva SA
17 May 22
Index to Unaudited Condensed Consolidated Financial Statements
7:00am
restrictive actions by governments;
differing reimbursement regimes and price controls in certain international markets;
negative consequences from … to the Quality Payment Program. At this time, the full impact to overall physician reimbursement under the Medicare
program as a result
6-K
EX-99.3
3rvi0
28 Jan 22
ObsEva Announces Corporate Updates
5:16pm
6-K/A
EX-99.2
uf8f2dy
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
5:24pm
6-K
EX-99.2
t5np zrqes
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
9:27am
F-3
EX-4.2
q30kpnmq2cxp0uua446
7 Aug 19
Shelf registration (foreign)
8:24am
6-K
EX-99.1
1uy7v7 r22k0x
7 Aug 19
Current report (foreign)
7:21am